Thrombosis in ovarian cancer: A case control study

British Journal of Cancer

Volumn 110, Issue 5, 2014, Pages 1118-1124

  Metcalf, R L ^a   Fry, D J ^a   Swindell, R ^a   McGurk, A ^a   Clamp, A R ^a   Jayson, G C ^a   Hasan, J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Deep venous thrombosis; DVT; Ovarian cancer; PE; Pulmonary embolism; Thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FEMORAL VEIN; HEMATEMESIS; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVARY CANCER; OVERALL SURVIVAL; PELVIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS; VERY ELDERLY; AGE; COHORT ANALYSIS; CORRELATION ANALYSIS; LOWER EXTREMITY DEEP VEIN THROMBOSIS; OUTCOME ASSESSMENT; PELVIC DEEP VEIN THROMBOSIS; PHYSICAL PERFORMANCE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PILOT PROJECTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 84895788060     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.3     Document Type: Article

References (17)

1. Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG (2012) Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 366(7): 601-609.
2. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandala M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M (2009) Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 10(10): 943-949.
3. Caine GJ, Stonelake PS, Lip GY, Kehoe ST (2002) The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 4(6): 465-473. (Pubitemid 35417069)
4. Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166(4): 458-464.
5. den Exter PL, Kooiman J, van der Hulle T, Huisman MV (2013) New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism. Best Pract Res Clin Haematol 26(2): 163-169.
6. Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N (2010) When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol 116(3): 374-377.
7. Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B, Pfisterer J, Sehouli J (2008) Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol 26(16): 2683-2689.
8. Fotopoulou C, Karavas A, Trappe R, Chekerov R, Lichtenegger W, Sehouli J (2009) Venous thromboembolism in recurrent ovarian cancer-patients: a systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO). Thromb Res 124(5): 531-535.
9. Gao S, Escalante C (2004) Venous thromboembolism and malignancy. Expert Rev Anticancer Ther 4(2): 303-320. (Pubitemid 38477344)
10. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007a) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110(10): 2339-2346. (Pubitemid 350100757)
11. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007b) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3): 632-634. (Pubitemid 46680709)
12. Lee AY, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA (2006) Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24(9): 1404-1408. (Pubitemid 46622005)
13. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17): 2189-2204.
14. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH (2007) Venous thromboembolism in ovarian cancer. Gynecol Oncol 105(3): 784-790. (Pubitemid 46734211)
15. Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K, Tanaka YO, Tsunoda H, Homma S, Yoshikawa H (2007) High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer 97(8): 1053-1057. (Pubitemid 47587007)
16. Tetsche MS, Norgaard M, Pedersen L, Lash TL, Sorensen HT (2006) Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study. BMC Cancer 6: 189.
17. Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda H, Yamaguchi I, Nagasawa T, Yoshikawa H, Aonuma K (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96(2): 290-295. (Pubitemid 46164734)